A detailed history of Penserra Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Penserra Capital Management LLC holds 3,126 shares of AZN stock, worth $207,034. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,126
Previous 30,843 89.86%
Holding current value
$207,034
Previous $2.41 Million 89.9%
% of portfolio
0.01%
Previous 0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $2.13 Million - $2.43 Million
-27,717 Reduced 89.86%
3,126 $243,000
Q2 2024

Aug 13, 2024

BUY
$66.81 - $80.83 $1.51 Million - $1.83 Million
22,663 Added 277.05%
30,843 $2.41 Million
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $229,961 - $262,139
-3,768 Reduced 31.54%
8,180 $554,000
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $114,372 - $128,029
1,848 Added 18.3%
11,948 $804,000
Q3 2023

Nov 15, 2023

BUY
$64.85 - $71.7 $321,656 - $355,632
4,960 Added 96.5%
10,100 $683,000
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $105,564 - $114,473
1,510 Added 41.6%
5,140 $367,000
Q1 2023

Apr 24, 2023

SELL
$63.15 - $71.6 $2.48 Million - $2.81 Million
-39,295 Reduced 91.54%
3,630 $251,000
Q4 2022

Feb 13, 2023

BUY
$54.21 - $70.44 $2.29 Million - $2.98 Million
42,295 Added 6713.49%
42,925 $2.91 Million
Q3 2022

Nov 14, 2022

SELL
$53.02 - $135.75 $915,496 - $2.34 Million
-17,267 Reduced 96.48%
630 $34,000
Q2 2022

Aug 15, 2022

BUY
$59.26 - $71.14 $1.06 Million - $1.27 Million
17,897 New
17,897 $1.18 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Penserra Capital Management LLC Portfolio

Follow Penserra Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Penserra Capital Management LLC with notifications on news.